Inventor · disambiguated record
Igor B. Roninson
Also filed as: RONINSON IGOR · RONINSON IGOR B
49 granted patents·36 pending applications·820 citations·filing 1984–2022
98Inventor score
Files withUNIV ILLINOIS38SENEX BIOTECHNOLOGY INC12UNIV SOUTH CAROLINA11RONINSON IGOR B3CHANG BEY-DIH2
Top patents by PatentIndex Score
85 records- 0194US5217889AMethods and applications for efficient genetic suppressor elementsRONINSON IGOR B·Filed 1990·Granted Jun 8, 1993·168 cites·3 claims
- 0287US5811234AMethods and applications for efficient genetic suppressor elementsUNIV ILLINOIS·Filed 1991·Granted Sep 22, 1998·107 cites·20 claims
- 0385US11014906B2Quinoline-based compounds and methods of inhibiting CDK8/19UNIV SOUTH CAROLINA·Filed 2019·Granted May 25, 2021·3 cites·19 claims
- 0485US9321737B2CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancerSENEX BIOTECHNOLOGY INC·Filed 2013·Granted Apr 26, 2016·9 cites·10 claims
- 0585US8598344B2CDKI pathway inhibitors and uses thereofPORTER DONALD C·Filed 2010·Granted Dec 3, 2013·17 cites·6 claims
- 0682US6479639B1Monoclonal antibody to a human MDR1 multidrug resistance gene product and usesUNIV ILLINOIS·Filed 2000·Granted Nov 12, 2002·8 cites·5 claims
- 0781US4675283ADetection and isolation of homologous, repeated and amplified nucleic acid sequencesMASSACHUSETTS INST TECHNOLOGY·Filed 1984·Granted Jun 23, 1987·44 cites·11 claims
- 0879US6326488B1Gene and genetic elements associated with sensitivity to chemotherapeutic drugsUNIV ILLINOIS·Filed 2000·Granted Dec 4, 2001·4 cites·8 claims
- 0978US5994088AMethods and reagents for preparing and using immunological agents specific for P-glycoproteinUNIV ILLINOIS·Filed 1996·Granted Nov 30, 1999·33 cites·14 claims
- 1077US9636342B2Method for treating prostate cancerUNIV SOUTH CAROLINA·Filed 2013·Granted May 2, 2017·4 cites·6 claims
- 1177US6537754B1Association of kinesin with sensitivity to chemotherapeutic drugsUNIV ILLINOIS·Filed 2000·Granted Mar 25, 2003·3 cites·8 claims
- 1277US5434075AMonoclonal antibody to a human MDR1 multidrug resistance gene product, and usesUNIV ILLINOIS·Filed 1992·Granted Jul 18, 1995·28 cites·7 claims
- 1376US5789389ABCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugsUNIV ILLINOIS·Filed 1995·Granted Aug 4, 1998·56 cites·4 claims
- 1475US6706491B1Reagents and methods for identifying and modulating expression of genes regulated by p21UNIV ILLINOIS·Filed 1999·Granted Mar 16, 2004·35 cites·15 claims
- 1573US6281011B1Methods and applications for efficient genetic suppressor elementsUNIV ILLINOIS·Filed 2000·Granted Aug 28, 2001·4 cites·21 claims
- 1673US5972598AMethods for preventing multidrug resistance in cancer cellsUNIV ILLINOIS·Filed 1995·Granted Oct 26, 1999·45 cites·29 claims
- 1773US5665550AGenes and genetic elements associated with sensitivity to chemotherapeutic drugsUNIV ILLINOIS·Filed 1995·Granted Sep 9, 1997·34 cites·93 claims
- 1871US6982313B2Genes and genetic elements associated with sensitivity to chemotherapeutic drugsUNIV ILLINOIS·Filed 2001·Granted Jan 3, 2006·1 cites·2 claims
- 1970US7235403B2Reagents and methods for identifying gene targets for treating cancerUNIV ILLINOIS·Filed 2002·Granted Jun 26, 2007·8 cites·14 claims
- 2070US6376241B1Methods and applications for efficient genetic suppressor elementsUNIV ILLINOIS·Filed 2000·Granted Apr 23, 2002·1 cites·6 claims
- 2168US6767705B2Reagents and methods for identifying and modulating expression of genes regulated by retinoidsUNIV ILLINOIS·Filed 2001·Granted Jul 27, 2004·2 cites·4 claims
- 2268US6171786B1Methods for preventing multidrug resistance in cancer cellsUNIV ILLINOIS·Filed 1996·Granted Jan 9, 2001·35 cites·25 claims
- 2365US6630327B1Methods and reagents for preparing and using immunological agents specific for P-glycoproteinUNIV ILLINOIS·Filed 1999·Granted Oct 7, 2003·17 cites·3 claims
- 2465US5206352ACompositions for clones containing DNA sequences associated with multidrug resistance in human cellsUNIV ILLINOIS·Filed 1990·Granted Apr 27, 1993·37 cites·8 claims
- 2565US2004166110A1Methods and reagent for preparing and using immunological agents specific for P-glycoproteinFiled 2003·Application pending·0 cites
- 2662US5942389AGenes and genetic elements associated with sensitivity to cisplatinUNIV ILLINOIS·Filed 1995·Granted Aug 24, 1999·16 cites·27 claims
- 2760US2010190807A1CDKI Pathway inhibitors and uses thereof to regulate expression to TAU proteinSENEX BIOTECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 2860US2020048208A1TREATMENT OF DISEASES OR DISORDERS CAUSED BY INDUCED NFkB TRANSCRIPTIONAL ACTIVITYSENEX BIOTECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 2959US7598340B2Monoclonal antibody to a human MDR1 multidrug resistance gene product, and usesUNIV ILLINOIS·Filed 2002·Granted Oct 6, 2009·0 cites·1 claims
- 3059US5464753APurification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expressionUNIV ILLINOIS·Filed 1993·Granted Nov 7, 1995·19 cites·8 claims
- 3159US2025127906A1Small-molecule degraders of cdk8 and cdk19UNIV SOUTH CAROLINA·Filed 2022·Application pending·0 cites
- 3258US12281080B2Quinoline-based compounds and methods of inhibiting CDK8/19UNIV SOUTH CAROLINA·Filed 2021·Granted Apr 22, 2025·0 cites·19 claims
- 3358US10993945B2CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancerSENEX BIOTECHNOLOGY INC·Filed 2016·Granted May 4, 2021·0 cites·4 claims
- 3458US2008241924A1Antibody-Mediated Induction of Tumor Cell DeathUNIV ILLINOIS·Filed 2008·Application pending·0 cites
- 3558US2004115206A1Antibody-mediated induction of tumor cell deathFiled 2003·Application pending·0 cites
- 3656US2003003543A1Methods and applications for efficient genetic suppressor elementsFiled 2002·Application pending·0 cites
- 3755US9409873B2CDKI pathway inhibitors and uses thereofSENEX BIOTECHNOLOGY INC·Filed 2013·Granted Aug 9, 2016·0 cites·4 claims
- 3855US5773280AMonoclonal antibody to a human MDR1 multidrug resistance gene product, and usesUNIV ILLINOIS·Filed 1993·Granted Jun 30, 1998·12 cites·7 claims
- 3955US2002099028A1Genes and genetic elements associated with control of neoplastic transformation in mammalian cellsUNIV ILLINOIS·Filed 2001·Application pending·0 cites
- 4054US6083746AGenes and genetic elements associated with control of neoplastic transformation in mammalian cellsUNIV ILLINOIS·Filed 1998·Granted Jul 4, 2000·7 cites·3 claims
- 4154US2004002097A1Association of kinesin with sensitivity to chemotherapeutic drugsFiled 2003·Application pending·0 cites
- 4253US2007154933A1Reagents and Methods for Identifying Gene Targets for Treating CancerUNIV ILLINOIS·Filed 2007·Application pending·0 cites
- 4353US2024390386A1Cdk8/19 inhibitors for preventing drug resistanceUNIV SOUTH CAROLINA·Filed 2022·Application pending·0 cites
- 4453US2014309224A1TREATMENT OF DISEASES OR DISORDERS CAUSED BY INDUCED NFkB TRANSCRIPTIONAL ACTIVITYRONINSON IGOR B·Filed 2012·Application pending·0 cites
- 4552US5866327AAssociation of kinensin with sensitivity to chemotherapeutic drugsUNIV ILLINOIS·Filed 1995·Granted Feb 2, 1999·6 cites·19 claims
- 4652US2024180921A1Cdk8/19 inhibitors for the treatment of cytokine stormUNIV SOUTH CAROLINA·Filed 2022·Application pending·0 cites
- 4752US2009208935A1Reagents and methods for identifying and modulating expression of tumor senescence genesSENEX BIOTECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 4850US2004175748A1Reagents and methods for identifying and modulating expression of genes regulated by p21Filed 2004·Application pending·0 cites
- 4949US6197521B1Genes and genetic elements associated with control of neoplastic transformation in mammalian cellsUNIV ILLINOIS·Filed 1999·Granted Mar 6, 2001·5 cites·9 claims
- 5049US6083745AGenes and genetic elements associated with control of neoplastic transformation in mammalian cellsUNIV ILLINOIS·Filed 1998·Granted Jul 4, 2000·8 cites·3 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Igor B. Roninson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →